[1] Simon EJ.Subunit structure and purification of opioid receptors[J]. Recept Res, 1987, 7(1/2/3/4): 105-132. [2] Zollner C, Schafer M.Opioids in anesthesia[J]. Anaesthesist, 2008, 57(7): 729-740. [3] Tai YH,Wang YH, Wang JJ, et al.Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats[J]. Pain, 2006, 124(1/2): 77-86. [4] Matthes HW, Maldonado R, Simonin F, et al.Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene[J]. Nature, 1996, 383(6603): 819-823. [5] Harrison LM, Kastin AJ, Zadina JE.Opiate tolerance and dependence: receptors, G-proteins, and antiopiates[J]. Peptides, 1998, 19(9): 1603-1630. [6] Ray SB, Gupta H, Gupta YK.Up-regulation of mu-opioid receptors in the spinal cord of morphine tolerant rats[J]. Biosci, 2004, 29(1): 51-56. [7] He L, Fong J, von ZM, et al. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization[J]. Cell, 2002, 108(2): 271-282. [8] Kim JA, Bartlett S, He L, et al.Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence[J]. Curr Biol, 2008, 18(2): 129-135. [9] Koch T, Widera A, Bartzsch K, et al.Receptor endocytosis counteracts the development of opioid tolerance[J]. Mol Pharmacol, 2005, 67(1): 280-287. [10] Whistler JL, Chuang HH, Chu P, et al.Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction[J]. Neuron, 1999, 23(4): 737-746. [11] Hull LC, Llorente J, Gabra BH, et al.The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy[J]. Pharmacol Exp Ther, 2010, 332(3): 1127-1135. [12] Sternini C, Brecha NC, Minnis J, et al.Role of agonist-dependent receptor internalization in the regulation of mu opioid receptors[J]. Neuroscience, 2000, 98(2): 233-241. [13] Von ZM, Svingos A, Haberstock-Debic H, et al.Regulated endocytosis of opioid receptors: cellular mechanisms and proposed roles in physiological adaptation to opiate drugs[J]. Curr Opin Neurobiol, 2003, 13(3): 348-353. [14] Koch T, Schulz S, Schroder H, et al.Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization[J]. Biol Chem, 1998, 273(22): 13652-13657. [15] Zeitz KP, Malmberg AB, Gilbert H, et al.Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice[J]. Pain, 2001, 94(3): 245-253. [16] Wang HL.A cluster of Ser/Thr residues at the C-terminus of mu-opioid receptor is required for G protein-coupled receptor kinase 2-mediated desensitization[J]. Neuropharmacology, 2000, 39(3): 353-363. [17] Narita M, Matsumura Y, Ozaki S, et al.Role of the calcium/calmodulin-dependent protein kinase ii (CaMKII) in the morphine-induced pharmacological effects in the mouse[J]. Neuroscience, 2004, 126(2): 415-421. [18] Doll C, Konietzko J, Poll F, et al.Agonist-selective patterns of micro-opioid receptor phosphorylation revealed by phosphosite-specific antibodies[J]. Br Pharmacol, 2011, 164(2): 298-307. [19] Smith FL, Javed RR, Smith PA, et al.PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice[J]. Pharmacol Res, 2006, 54(6): 474-480. [20] He SQ, Zhang ZN, Guan JS, et al.Facilitation of mu-opioid receptor activity by preventing delta-opioid receptor-mediated codegradation[J]. Neuron, 2011, 69(1): 120-131. [21] Koch T, Brandenburg LO, Liang Y, et al.Phospholipase D2 modulates agonist-induced mu-opioid receptor desensitization and resensitization[J]. Neurochem, 2004, 88(3): 680-688. [22] Grecksch G, Bartzsch K, Widera A, et al.Development of tolerance and sensitization to different opioid agonists in rats[J]. Psychopharmacology(Berl), 2006, 186(2): 177-184. [23] Borgland SL, Connor M, Osborne PB, et al.Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors[J]. Biol Chem, 2003, 278(21): 18776-18784. [24] Wang YH, Sun JF, Tao YM, et al.Paradoxical relationship between RAVE (relative activity versus endocytosis) values of several opioid receptor agonists and their liability to cause dependence[J]. Acta Pharmacol Sin, 2010, 31(4): 393-398. [25] Martini L,Whistler JL.The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence[J]. Curr Opin Neurobiol, 2007, 17(5): 556-564. [26] Koch T, Hollt V.Role of receptor internalization in opioid tolerance and dependence[J]. Pharmacol Ther, 2008, 117(2): 199-206. [27] Sharma SK, Klee WA, Nirenberg M.Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance[J]. Proc Natl Acad Sci USA, 1975, 72(8): 3092-3096. [28] Shen KF, Crain SM.Cholera toxin-B subunit blocks excitatory effects of opioids on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions[J]. Brain Res, 1990, 531(1/2): 1-7. [29] Avidor-Reiss T, Nevo I, Levy R, et al.Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma[J]. Biol Chem, 1996, 271(35): 21309-21315. [30] Finn AK, Whistler JL.Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal[J]. Neuron, 2001, 32(5): 829-839. [31] Lopez-Gimenez JF,Vilaro MT, Milligan G.Morphine desensitization, internalization, and down- regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation[J]. Mol Pharmacol, 2008, 74(5): 1278-1291. [32] Fuxe K, Borroto-Escuela DO, Marcellino D, et al.GPCR heteromers and their allosteric receptor-receptor interactions[J]. Curr Med Chem, 2012, 19(3): 356-363. [33] Agnati LF, Guidolin D, Leo G, et al.Possible new targets for GPCR modulation: allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms[J]. Recept Signal Transduct Res, 2011, 31(5): 315-331. |